Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (61-70 of 304) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2006
Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitorsA Kendall, M Dowsett, E Folkerd, et al.
Cancer Treatment and Research|January 1, 1988
Aromatase inhibitors as new endocrine therapy for breast cancerA M Brodie, M Dowsett, R C Coombes
British Journal of Cancer|November 1, 1990
A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patientsM Dowsett, A Mehta, J Mansi, et al.
Fertility and Sterility|May 1, 1991
The effect of danazol on pulsatile gonadotropin secretion in women with endometriosisP Maouris, M Dowsett, D K Edmonds, et al.
Lancet (London, England)|May 6, 1995
p53 protein overexpression and chemosensitivity in breast cancerA Makris, T J Powles, M Dowsett, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Steroid hormone profile in postmenopausal women with ovarian cancerM E O'Brien, M Dowsett, I Fryatt, et al.
Lancet (London, England)|May 6, 1989
A new treatment for endometriosisP Maouris, M Dowsett, G Rose, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemopreventionG Davies, L A Martin, N Sacks, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 4, 2007
Aromatase inhibitors and male breast cancerE Arriola, E Hui, M Dowsett, et al.
Clinical Therapeutics|January 1, 1992
Clinical and endocrine effects of leuprorelin acetate in pre- and postmenopausal patients with advanced breast cancerM Dowsett, S Jacobs, J Aherne, et al.
Pageof 31

Showing results (61-70 of 304) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2006
Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitorsA Kendall, M Dowsett, E Folkerd, et al.
Cancer Treatment and Research|January 1, 1988
Aromatase inhibitors as new endocrine therapy for breast cancerA M Brodie, M Dowsett, R C Coombes
British Journal of Cancer|November 1, 1990
A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patientsM Dowsett, A Mehta, J Mansi, et al.
Fertility and Sterility|May 1, 1991
The effect of danazol on pulsatile gonadotropin secretion in women with endometriosisP Maouris, M Dowsett, D K Edmonds, et al.
Lancet (London, England)|May 6, 1995
p53 protein overexpression and chemosensitivity in breast cancerA Makris, T J Powles, M Dowsett, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Steroid hormone profile in postmenopausal women with ovarian cancerM E O'Brien, M Dowsett, I Fryatt, et al.
Lancet (London, England)|May 6, 1989
A new treatment for endometriosisP Maouris, M Dowsett, G Rose, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemopreventionG Davies, L A Martin, N Sacks, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 4, 2007
Aromatase inhibitors and male breast cancerE Arriola, E Hui, M Dowsett, et al.
Clinical Therapeutics|January 1, 1992
Clinical and endocrine effects of leuprorelin acetate in pre- and postmenopausal patients with advanced breast cancerM Dowsett, S Jacobs, J Aherne, et al.
Pageof 31